Trial intelligence / Profile preview

Antimicrobial peptides as surgical hand disinfectants

IRCT20190924044863N4Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Jun 2025
Modality
Small Molecules, Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of nisin, melittin, pexiganan and omiganan in surgical site infection (SSI), sponsored by Mashhad University of Medical Sciences. Started Jun 2025; status: completed.

02

Drugs

nisinmelittinpexigananomiganan
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on IRCT20190924044863N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190924044863N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call